Profile data is unavailable for this security.
About the company
Premier, Inc. is a healthcare improvement company uniting an alliance of approximately 4,350 United States hospitals and health systems and approximately 300,000 other providers and organizations. It operates through two segments: Supply Chain Services and Performance Services. The Supply Chain Services segment includes the Company’s group purchasing organizations (GPO), supply chain co-management, purchased services, and direct sourcing activities. The Performance Services segment consists of three sub-brands, which include PINC AI, the Company’s technology and services platform; Contigo Health, the Company’s direct-to-employer business; and Remitra, the Company’s digital invoicing and payables business. It delivers technology-enabled platform that offers critical supply chain services, clinical, financial, operational and value-based care software as a service (SaaS) as well as clinical and enterprise analytics licenses, consulting services, and third-party administrator services.
- Revenue in USD (TTM)1.34bn
- Net income in USD80.33m
- Incorporated2013
- Employees2.80k
- LocationPremier Inc13034 Ballantyne Corporate PlaceCHARLOTTE 28277United StatesUSA
- Phone+1 (704) 357-0022
- Fax+1 (302) 655-5049
- Websitehttps://www.premierinc.com/
Peer analysis
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Inmode Ltd | 466.26m | 181.11m | 1.58bn | 581.00 | 8.89 | 1.90 | 8.72 | 3.40 | 2.11 | 2.11 | 5.42 | 9.87 | 0.5973 | 1.71 | 16.09 | 802,509.40 | 23.20 | 31.32 | 25.21 | 35.64 | 83.10 | 84.46 | 38.84 | 39.65 | 12.66 | -- | 0.00 | 0.00 | 8.32 | 37.49 | 22.54 | 54.65 | 13.10 | -- |
Alphatec Holdings Inc | 511.63m | -191.60m | 1.64bn | 839.00 | -- | 44.52 | -- | 3.21 | -1.49 | -1.49 | 3.97 | 0.4294 | 0.7612 | 1.34 | 6.70 | 609,808.10 | -28.51 | -30.97 | -37.13 | -39.47 | 65.89 | 66.02 | -37.45 | -46.22 | 1.49 | -5.17 | 0.8938 | -- | 37.45 | 39.38 | -23.36 | -- | 67.92 | -- |
Rxsight Inc | 101.10m | -44.50m | 1.84bn | 374.00 | -- | 10.70 | -- | 18.19 | -1.25 | -1.25 | 2.83 | 4.41 | 0.5243 | 2.01 | 5.91 | 270,323.50 | -23.07 | -- | -25.25 | -- | 63.39 | -- | -44.01 | -- | 8.18 | -- | 0.0009 | -- | 81.77 | -- | 27.19 | -- | -- | -- |
LeMaitre Vascular Inc | 199.89m | 33.95m | 1.94bn | 614.00 | 57.30 | 6.29 | 44.63 | 9.71 | 1.51 | 1.51 | 8.89 | 13.74 | 0.5977 | 1.17 | 7.19 | 325,548.90 | 10.15 | 9.02 | 10.99 | 9.93 | 66.45 | 65.83 | 16.99 | 15.45 | 5.31 | -- | 0.00 | 40.41 | 19.69 | 12.88 | 45.89 | 5.96 | 18.93 | 15.51 |
Warby Parker Inc | 697.80m | -55.06m | 1.96bn | 2.14k | -- | 6.21 | -- | 2.82 | -0.467 | -0.467 | 5.91 | 2.66 | 1.21 | 5.19 | 655.52 | 326,074.80 | -9.57 | -- | -11.95 | -- | 55.01 | 57.49 | -7.89 | -14.53 | 2.02 | -- | 0.00 | -- | 11.98 | 19.67 | 42.75 | -- | -- | -- |
Novocure Ltd | 525.66m | -192.74m | 2.06bn | 1.45k | -- | 5.72 | -- | 3.91 | -1.81 | -1.81 | 4.92 | 3.34 | 0.4579 | 3.57 | 7.51 | 361,774.90 | -16.79 | -7.74 | -19.40 | -8.95 | 74.82 | 77.22 | -36.67 | -14.69 | 5.99 | -- | 0.6132 | -- | -5.30 | 15.47 | -123.75 | -- | 32.19 | -- |
Premier Inc | 1.34bn | 80.33m | 2.07bn | 2.80k | 30.81 | 1.08 | 10.53 | 1.55 | 0.6421 | 0.6421 | 11.34 | 18.35 | 0.3887 | 5.25 | 3.10 | 477,306.10 | 1.89 | 10.39 | 2.48 | 13.00 | 66.20 | 62.04 | 4.87 | 22.60 | 0.8226 | 143.62 | 0.276 | 19.11 | -6.76 | 2.44 | -34.17 | -15.30 | -2.29 | -- |
STAAR Surgical Co | 326.24m | 15.30m | 2.17bn | 1.06k | 142.99 | 5.53 | 104.99 | 6.66 | 0.3093 | 0.3093 | 6.62 | 8.00 | 0.7159 | 2.11 | 5.09 | 308,942.30 | 3.36 | 6.77 | 3.82 | 7.90 | 78.51 | 76.89 | 4.69 | 9.16 | 5.22 | -- | 0.0004 | 0.00 | 13.37 | 21.07 | -46.18 | 33.85 | 51.95 | -- |
Conmed Corp | 1.26bn | 82.35m | 2.27bn | 4.00k | 28.07 | 2.65 | 14.69 | 1.80 | 2.62 | 2.62 | 40.12 | 27.76 | 0.545 | 1.73 | 5.55 | 315,387.00 | 3.56 | 0.8972 | 4.10 | 1.02 | 54.92 | 54.95 | 6.53 | 1.65 | 1.08 | 3.65 | 0.5369 | 139.16 | 19.06 | 7.68 | 179.99 | 10.04 | 2.89 | 0.00 |
Patterson Companies, Inc. | 6.57bn | 185.93m | 2.32bn | 7.60k | 13.19 | 2.36 | 8.46 | 0.3525 | 2.00 | 2.00 | 70.16 | 11.16 | 2.27 | 6.58 | 12.82 | 864,246.30 | 6.42 | 1.13 | 11.05 | 1.81 | 21.01 | 20.98 | 2.82 | 0.5157 | 0.7473 | 14.91 | 0.389 | 304.75 | 1.50 | 3.34 | -10.42 | 18.10 | 2.17 | 0.00 |
Quidelortho Corp | 2.86bn | -1.76bn | 2.33bn | 7.10k | -- | 0.7038 | -- | 0.8153 | -26.38 | -26.38 | 42.82 | 49.52 | 0.3696 | 2.67 | 8.92 | 403,197.20 | -22.79 | 11.34 | -25.57 | 12.91 | 48.13 | 62.71 | -61.65 | 20.93 | 0.807 | 0.8786 | 0.4207 | 0.00 | -8.21 | 41.83 | -101.84 | -- | 45.87 | -- |
10X Genomics Inc | 625.45m | -264.30m | 2.38bn | 1.26k | -- | 3.30 | -- | 3.80 | -2.24 | -2.24 | 5.30 | 6.01 | 0.6458 | 2.67 | 7.39 | 496,781.60 | -27.29 | -25.52 | -30.80 | -29.05 | 64.62 | 75.88 | -42.26 | -48.53 | 4.45 | -- | 0.00 | -- | 19.81 | 33.43 | -53.67 | -- | 49.15 | -- |
Evolent Health Inc | 2.18bn | -141.23m | 2.42bn | 4.70k | -- | 2.28 | -- | 1.11 | -1.25 | -1.25 | 19.28 | 10.72 | 0.8316 | -- | 6.30 | 462,948.70 | -4.22 | -9.60 | -5.36 | -12.59 | 20.56 | 24.50 | -5.07 | -13.66 | -- | -0.0548 | 0.3272 | -- | 45.26 | 25.65 | -660.71 | -- | -6.18 | -- |
UFP Technologies Inc | 407.33m | 47.88m | 2.43bn | 3.09k | 51.04 | 8.24 | 40.84 | 5.97 | 6.21 | 6.21 | 52.82 | 38.46 | 1.02 | 4.50 | 6.71 | 131,693.20 | 11.99 | 9.69 | 13.80 | 10.95 | 27.89 | 26.33 | 11.75 | 10.14 | 1.46 | 17.87 | 0.1039 | 0.00 | 13.08 | 16.00 | 7.50 | 25.71 | 14.08 | -- |
Myriad Genetics, Inc. | 774.20m | -234.60m | 2.45bn | 2.70k | -- | 3.23 | -- | 3.17 | -2.82 | -2.82 | 9.11 | 8.40 | 0.6792 | 10.41 | 6.53 | 286,740.80 | -20.58 | -- | -23.57 | -- | 68.79 | -- | -30.30 | -- | 1.82 | -225.20 | 0.0485 | -- | 11.03 | -- | -135.09 | -- | -- | -- |
Integra Lifesciences Holdings Corp | 1.53bn | 40.23m | 2.49bn | 3.95k | 62.32 | 1.56 | 15.28 | 1.63 | 0.5079 | 0.5079 | 19.32 | 20.29 | 0.3912 | 1.56 | 6.06 | 387,632.80 | 1.03 | 3.33 | 1.11 | 3.68 | 61.48 | 63.67 | 2.63 | 7.99 | 3.35 | 6.66 | 0.5374 | 0.00 | -1.03 | 0.9219 | -62.48 | 2.19 | -2.97 | -- |
Holder | Shares | % Held |
---|---|---|
BlackRock Fund Advisorsas of 31 Mar 2024 | 14.62m | 13.94% |
The Vanguard Group, Inc.as of 31 Mar 2024 | 13.67m | 13.04% |
Dimensional Fund Advisors LPas of 31 Mar 2024 | 4.92m | 4.69% |
SSgA Funds Management, Inc.as of 31 Mar 2024 | 4.22m | 4.03% |
First Trust Advisors LPas of 31 Mar 2024 | 4.06m | 3.87% |
Newport Trust Co.as of 31 Mar 2024 | 2.57m | 2.45% |
Norges Bank Investment Managementas of 31 Dec 2023 | 2.29m | 2.19% |
Geode Capital Management LLCas of 31 Mar 2024 | 1.98m | 1.89% |
Charles Schwab Investment Management, Inc.as of 31 Mar 2024 | 1.58m | 1.51% |
Parametric Portfolio Associates LLCas of 31 Mar 2024 | 1.52m | 1.45% |